China trial of Gilead's potential coronavirus treatment suspended

A trial in China testing Gilead Sciences Inc's antiviral drug, remdesivir, in those with mild symptoms of COVID-19 has been suspended due to a lack of eligible patients, according to a website maintained by the U.S. government.